MIHNEA-THEODOR SIRBU

Dr. MIHNEA-THEODOR SIRBU

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2023 in Polymers
Verified
Journal Article
Open access
PDF file
LSLiliana Savin
Liliana Savin
TPTudor Pinteala
Tudor Pinteala
DMDana Nicoleta Mihai
Dana Nicoleta Mihai
DMDan Mihailescu
Dan Mihailescu
SMSmaranda Stefana Miu
Smaranda Stefana Miu
NFNorin FORNA
Norin FORNA
One of the most popular and effective orthopedic surgical interventions for treating a variety of hip diseases is total hip arthroplasty. Despite being a radical procedure that involves replacing bone and cartilaginous surfaces with biomaterials, it produces excellent outcomes that significantly increase the patient’s quality of life. Patient factors and surgical technique, as well as biomaterials, play a role in prosthetic survival, with aseptic loosening (one of the most common causes of total hip arthroplasty failure) being linked to the quality of biomaterials utilized. Over the years, various biomaterials have been developed to limit the amount of wear particles generated over time by friction between the prosthetic head (metal alloys or ceramic) and the insert fixed in the acetabular component (polyethylene or ceramic). An ideal biomaterial must be biocompatible, have a low coefficient of friction, be corrosion resistant, and have great mechanical power. Comprehensive knowledge regarding what causes hip arthroplasty failure, as well as improvements in biomaterial quality and surgical technique, will influence the survivability of the prosthetic implant. The purpose of this article was to assess the benefits and drawbacks of various biomaterial and friction couples used in total hip arthroplasties by reviewing the scientific literature published over the last 10 years.

21 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
OBOANA BADULESCU
OANA BADULESCU
Iris Bararu BojanIris Bararu Bojan
Iris Bararu Bojan
Minerva Codruta BadescuMinerva Codruta Badescu
Minerva Codruta Badescu
Nina FilipNina Filip
Nina Filip
ACAlina Chelsău
Alina Chelsău
PSPaul-Dan Sirbu
Paul-Dan Sirbu
Haemophilia is a rare genetic disorder, that results from various degrees of deficiency of coagulation factor VIII (haemophilia A), or factor IX (haemophilia B), with an X-linked transmission. The patients affected are in the majority of cases males (who inherit the affected X-chromosome from the maternal side), with rare cases of females with haemophilia (FVIII or FIX < 40 IU/dL), situations in which both X-chromosomes are affected, or one is affected, and the other one is inactive (known as carrier). The hypocoagulable state due to the deficiency of clotting factors, manifests as an excessive, recurrent tendency to bleeding, which positively correlates with plasmatic levels. Severe haemophilia results in hemarthrosis, although recent data have shown that moderate or even mild disease can lead to joint bleeding. Recurrent episodes of haemorrhages, usually affecting large joints such as knees, elbows, or ankles, lead to joint remodelling and subsequent haemophilic arthropathy, which may require arthroplasty as a last therapeutic option. Orthopaedic patients have the highest risk among all for deep vein thrombosis (DVT) and venous thromboembolism (VTE) with morbid and potentially fatal consequences. While for the rest of the population thromboprophylaxis in orthopaedic surgery is efficient, relatively safe, and widely used, for patients with haemophilia who are considered to have a low thromboembolic risk, there is great controversy. The great heterogeneity of this particular population, and the lack of clinical trials, with only case reports or observational studies, makes thromboprophylaxis in major orthopaedic surgery a tool to be used by every clinician based on experience and case particularities. This review aims to briefly summarise the latest clinical data and to offer an insight into the current recommendations that readers would find useful in daily practice.

25 May 2024 in Polymers
Verified
Journal Article
Open access
PDF file
PCPetru Ciobanu
Petru Ciobanu
MDMihai Danciu
Mihai Danciu
PAPascu Andrei
Pascu Andrei
IGIoannis Gardikiotis
Ioannis Gardikiotis
NFNorin FORNA
Norin FORNA
PSPaul-Dan Sirbu
Paul-Dan Sirbu
Background: A critical-sized bone defect (CsBD) is considered one that will not heal spontaneously and requires reconstruction. This study aims to compare the results of using different bone reconstructive techniques and to study the potential of platelet-rich fibrin (PRF) to enhance the healing properties of a bone substitute (BS). Methods: In this experimental study on rats, the treatment of critical-sized bone defects was carried out by analysing four groups: a control group in which the bone defect was left empty; a group treated with Bio-Gen®; another group in which the defect was treated with PRF in combination with Bio-Gen®; and the last that was treated with autologous bone graft (ABG). The defects were evaluated by microcomputed tomography (µCT) and then histomorphometrically. Results: From both the histological and imagistic point of view, the best results were registered in the ABG group, followed by the group treated with Bio-Gen® with PRF, Bio-Gen® group, and control group, with statistically significant differences. Conclusions: A 5 mm defect in the rat radius can be considered critical. ABG showed the best results in treating the bone defect. PRF significantly enhanced the efficacy of Bio-Gen®.

22 March 2025 in Medicina
Verified
Journal Article
Open access
PDF file
OBOANA BADULESCU
OANA BADULESCU
PSPaul-Dan Sirbu
Paul-Dan Sirbu
Manuela CiocoiuManuela Ciocoiu
Manuela Ciocoiu
MVMaria Cristina Vladeanu
Maria Cristina Vladeanu
Carmen Elena PleșoianuCarmen Elena Pleșoianu
Carmen Elena Pleșoianu
Iris Bararu BojanIris Bararu Bojan
Iris Bararu Bojan
Background and Objectives: Total hip replacement and total knee arthroplasty carry a high risk of postoperative venous thromboembolism (VTE); therefore, anticoagulation prophylaxis is recommended in these patients. Unfortunately, there are no guidelines about VTE prophylaxis in patients with hemophilia who underwent these high-risk surgeries. To determine whether these patients have a high risk of VTE, we conducted a retrospective study on patients with hemophilia who underwent elective arthroplasty at our hospital in 2016. Materials and Methods: There were 11 patients with hemophilia A and B who underwent high-risk surgeries. Recombinant factor VIII or IX and also active recombinant Factor VII were used for perioperative hemostasis, and LMWH was administered for thromboembolic prophylaxis. Postoperatively, we collected information on the duration of factor VIII/IX infusion, VTE-prophylaxis, and complications. Results: Postoperative bleeding was minimal in most cases, with an average blood loss of 500 mL. No major thrombotic events were reported, and the need for transfusion was low, with only one patient requiring additional blood products. The VTE prophylaxis included prophylactic enoxaparin and hemostatic treatment. At the 1-year follow-up, we did not find any evidence of clinical VTE in our patients. Conclusions: Better risk stratification is needed to identify patients who would benefit from pharmacological prophylaxis. Total arthroplasty in hemophilic patients is feasible and safe when managed by a multidisciplinary team and supported by tailored antithrombotic prophylaxis protocols. The use of recombinant coagulation factors and LMWH ensures effective bleeding control and thromboembolic prevention, enhancing patient outcomes. These findings underscore the importance of individualized care in this high-risk population.

15 February 2026 in Life
Verified
Journal Article
Open access
PDF file
ACAdrian Claudiu Carp
Adrian Claudiu Carp
BVBogdan Veliceasa
Bogdan Veliceasa
ADAwad Dmour
Awad Dmour
AFAlexandru Filip
Alexandru Filip
MPMihaela Pertea
Mihaela Pertea
PSPaul-Dan Sirbu
Paul-Dan Sirbu
Fractures of the pelvic ring are among the most severe injuries in orthopaedic practice and Tile type C lesions are characterized by complete disruption of the posterior arch with both vertical and rotational instability. The optimal construct for posterior ring fixation remains a matter of debate. The aim of this study was to compare, by means of finite element analysis, the biomechanical performance of three different methods of osteosynthesis for Tile type C1.2 pelvic ring fractures: a transiliac plate, one iliosacral screw and two anterior reconstruction plates on the sacroiliac joint. A three-dimensional model of an intact pelvis was reconstructed from computed tomography images of a healthy adult male. A Tile type C1.2 injury pattern was created virtually, and three fixation constructs were designed in Ansys SpaceClaim according to manufacturer specifications. All materials were assumed to be homogeneous, isotropic and linearly elastic. Vertical loads of 400 N and 800 N were applied to the sacral endplate to simulate partial and full weight bearing, while the acetabular regions were constrained to represent standing stance. In this study, mechanical stability was operationally defined as resistance to global displacement under applied vertical load, with lower displacement indicating higher construct stiffness. Construct stiffness, total deformation and von Mises stress were assessed for bone and implants. For both loading conditions, the iliosacral screw construct showed the lowest overall displacement and provided the greatest stiffness. The transiliac plate construct presented larger displacements, whereas the anterior reconstruction plate construct provided intermediate stability with higher stresses at the sacroiliac joint. Among the analyzed constructs, the iliosacral screw provided the greatest stiffness and lowest overall displacement, suggesting superior mechanical performance under vertical loading conditions.

30 March 2019 in Materiale Plastice
Verified
Journal Article
Closed access
ASAndrei Scripcaru
Andrei Scripcaru
NFNorin Forna
Norin Forna
ACAlexandru Bogdan Ciubara
Alexandru Bogdan Ciubara
HBHorea Rares Ciprian Benea
Horea Rares Ciprian Benea
VVVlad Veringa
Vlad Veringa
PSPaul-Dan Sirbu
Paul-Dan Sirbu
Some disadvantages of traditional metallic implants used in orthopedics and traumatology prompted the development of bioresorbable polymer devices.The aim of this experimental study is to emphasize the characteristics of INION� resorbable implants (regarding design and polymers compositions), as well as to evaluate the results when using these innovative implants in two trauma cases. The polymers used in manufacturing INION� devices (Trimethylene Carbonate/TMC; L-Polylactic acid/LPLA; D,L Polylactic acid/DLPLA; Polyglycolic acid/PGA) degrade in alpha-hydroxy acids, gradually losing their hardness in 18-36 weeks with a complete bioresorption of 2-4 years. The clinical cases demonstrated the advantages of INION� plates (adapted shape, low profile, polyaxial screws, acceptable strength) or pins (allowing the aligmment and fixation of fracture, no migration). Among our patients, we found excellent results concerning the maintaining of primary reduced fracture, active range of motion, minimal pain with improving everyday comfort, no tissue or implant complications. Bioresorbable fracture fixation INION� devices are a viable alternative to traditional metallic implants, offering same significant advantages over them: the avoidance of long-term interference with gliding structures, keeping their strength long enough to support bone healing, no need to remove the implants, less pain, radiolucency, elimination of stress shielding and a lower risk of complications.